195 related articles for article (PubMed ID: 19384589)
1. PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia.
Saleem S; Ahmad AS; Maruyama T; Narumiya S; Doré S
Neurotox Res; 2009 Jan; 15(1):62-70. PubMed ID: 19384589
[TBL] [Abstract][Full Text] [Related]
2. Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.
Saleem S; Kim YT; Maruyama T; Narumiya S; Doré S
J Neuroimmunol; 2009 Mar; 208(1-2):87-93. PubMed ID: 19203800
[TBL] [Abstract][Full Text] [Related]
3. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment.
Stjernschantz J; Selén G; Astin M; Resul B
Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity.
Kim YT; Moon SK; Maruyama T; Narumiya S; Doré S
Neurobiol Dis; 2012 Oct; 48(1):58-65. PubMed ID: 22709986
[TBL] [Abstract][Full Text] [Related]
5. Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.
Sharif NA; Kelly CR; Crider JY
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):715-21. PubMed ID: 12556403
[TBL] [Abstract][Full Text] [Related]
6. Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor.
Crowston JG; Lindsey JD; Aihara M; Weinreb RN
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3555-9. PubMed ID: 15452062
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function.
Hamill CE; Mannaioni G; Lyuboslavsky P; Sastre AA; Traynelis SF
Exp Neurol; 2009 May; 217(1):136-46. PubMed ID: 19416668
[TBL] [Abstract][Full Text] [Related]
8. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
[TBL] [Abstract][Full Text] [Related]
9. Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors.
Ikeda-Matsuo Y; Tanji H; Ota A; Hirayama Y; Uematsu S; Akira S; Sasaki Y
Br J Pharmacol; 2010 Jun; 160(4):847-59. PubMed ID: 20590584
[TBL] [Abstract][Full Text] [Related]
10. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytosolic phospholipase A(2) alpha protects against focal ischemic brain damage in mice.
Zhang J; Barasch N; Li RC; Sapirstein A
Brain Res; 2012 Aug; 1471():129-37. PubMed ID: 22819928
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury.
Ahmad M; Ahmad AS; Zhuang H; Maruyama T; Narumiya S; Doré S
J Neuroimmunol; 2007 Mar; 184(1-2):172-9. PubMed ID: 17275922
[TBL] [Abstract][Full Text] [Related]
13. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
Errasti AE; del-Rey G; Cesio CE; Souza G; Nowak W; Pelorosso FG; Daray FM; Rothlin RP
Eur J Pharmacol; 2009 May; 610(1-3):68-74. PubMed ID: 19289115
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.
Kawano T; Anrather J; Zhou P; Park L; Wang G; Frys KA; Kunz A; Cho S; Orio M; Iadecola C
Nat Med; 2006 Feb; 12(2):225-9. PubMed ID: 16432513
[TBL] [Abstract][Full Text] [Related]
15. The effects of prostaglandin analogues on intracellular Ca2+ in ciliary arteries of wild-type and prostanoid receptor-deficient mice.
Abe S; Watabe H; Takaseki S; Aihara M; Yoshitomi T
J Ocul Pharmacol Ther; 2013 Feb; 29(1):55-60. PubMed ID: 23046436
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice.
Ahmad AS; Ahmad M; Maruyama T; Narumiya S; Doré S
Age (Dordr); 2010 Sep; 32(3):271-82. PubMed ID: 20640551
[TBL] [Abstract][Full Text] [Related]
17. Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent.
Smith-Thomas L; Moustafa M; Spada CS; Shi L; Dawson RA; Wagner M; Balafa C; Kedzie KM; Reagan JW; Krauss AH; Woodward DF; MacNeil S
Exp Eye Res; 2004 May; 78(5):973-85. PubMed ID: 15051478
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice.
Iadecola C; Sugimoto K; Niwa K; Kazama K; Ross ME
J Cereb Blood Flow Metab; 2001 Dec; 21(12):1436-41. PubMed ID: 11740205
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
Walch L; Clavarino E; Morris PL
Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter.
Ansari HR; Kaddour-Djebbar I; Abdel-Latif AA
Exp Eye Res; 2004 Feb; 78(2):285-96. PubMed ID: 14729360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
